---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-158353"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:18:56.961605+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Shareholders elect directors and approve advisory proposals at 2024 annual meeting

## Summary
- Elected Ted White (13,091,028 for) and Mark Prygocki (12,503,147 for) as directors.
- Advisory vote on executive compensation approved: 12,760,245 for, 1,932,076 against.
- Advisory vote on frequency of say-on-pay: one year selected with 14,797,140 votes.
- Ratification of KPMG LLP as independent auditor approved: 37,151,871 for, 678,830 against.
- Approximately 89.2% of outstanding shares were present or represented at the meeting.

## SEC filing metadata
- accession: 0001193125-24-158353
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/0001193125-24-158353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/d834681d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-158353
- JSON: https://secwatch.observer/filing/0001193125-24-158353.json
- Plain text: https://secwatch.observer/filing/0001193125-24-158353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.